GastroLab India Pvt. Ltd

What GastroLab India Pvt. Ltd does

GastroLab India Pvt. Ltd is a Pune-based, privately held diagnostic company founded in 2017 that markets itself as India's first diagnostic firm focused specifically on digestive disorders. The company operates a thin asset-light model combining direct-to-consumer e-commerce (gastrolab.com online shop), a free online risk-assessment suite covering gastric function, GI inflammation, small-intestine/pancreatic risk, and colon disease, and a partner network of 14+ hospitals and specialty clinics across Maharashtra and Madhya Pradesh that perform specimen collection and specialist referrals.

The core product set is built on non-invasive biomarker assays sourced from global technology partners rather than proprietary IP. Flagship products include GastroPanel (a 4-biomarker blood test measuring Pepsinogen I, Pepsinogen II, Gastrin-17, and H. pylori IgG via BioHit technology), Peptest (a saliva-based pepsin-detection reflux assay using RDBIOMED's monoclonal antibody platform), NutriSMART (a 57-food IgG4 intolerance test from DST Diagnostics), and complementary assays — Calprotectin, Active B12, ColonView FOB, Celiac Quick Test, Zonulin, Pancreatic Elastase, FilmArray GI Panel, and Vitamin D ELISA — covering the inflammatory, infectious, malabsorption, and nutritional facets of GI disease. GastroLab does not own underlying assay patents; its defensibility rests on distribution, clinical workflow integration, and brand as India's first focused GI-diagnostic player.

Revenue mechanics are predominantly transactional: per-test kit sales through the online shop and partner-network specimen collection, with freemium online assessments functioning as a top-of-funnel lead generator that converts users into paid test purchases. A secondary B2B revenue stream — corporate employee gastric-disorder screening, particularly targeting workers aged 45+ — has been explicitly marketed with at least one employer case-study testimonial. Pricing is not publicly disclosed; the website shop displays placeholder pricing at ₹0.00, and enterprise/channel pricing is quote-based. With 23 employees, no disclosed funding, no management bios, and a website copyright terminating in 2020, GastroLab appears to be a small, bootstrap-style operating company rather than a venture-backed scale-up.

Name

GastroLab India Pvt. Ltd

Legal name

GastroLab India Pvt. Ltd

Website

https://gastrolab.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

GastroLab India Pvt. Ltd is a Pune-based diagnostic company and India's first focused digestive-disorders lab, offering non-invasive biomarker tests (GastroPanel, Peptest, NutriSMART) and online risk assessments through a 14+ partner hospital network across Maharashtra and Madhya Pradesh.

Ownership category

akta.pro rank

Product category

Gastrointestinal Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

General Gastroenterology (HLAKAEAA)

akta.pro secondary industries

Gastroenterology Telemedicine Platforms (HLALAGAE), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

Keywords

• Gastrointestinal diagnostics
• Non-invasive diagnostic testing
• Digestive disorder screening
• Biomarker blood assays
• Online health assessments

Headquarters

HQ city

Pune

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Diagnostic Test Sales: GastroLab generates revenue through the sale of diagnostic test kits including GastroPanel, Peptest, NutriSMART, and other specialty GI tests. Tests are ordered through the online shop and performed at partner locations or self-collected.
2. Online Assessment Services: Free and paid online health risk assessments for various digestive conditions. Assessments guide patients toward appropriate diagnostic testing.
3. Laboratory Testing Services: Partner network of hospitals and clinics provides specimen collection and testing services. GastroLab supplies technology and test kits to these partners.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

GastroLab India Pvt. Ltd provides non-invasive gastrointestinal diagnostic testing services for digestive disorders, combining free online risk assessment tools with a portfolio of blood, saliva, and stool-based biomarker tests. The core offering centers on GastroPanel, Peptest, NutriSMART, and additional GI assays delivered either directly to consumers via an online shop or through a network of 14+ partner hospitals and clinics across India.

Product overview

GastroLab is India's first diagnostic company focused on digestive disorders, offering a platform combining online risk assessment tools with a comprehensive portfolio of diagnostic tests. The platform integrates four key product lines: (1) GastroPanel - a 4-biomarker blood test providing stomach mucosa status, H. pylori infection, and achlorhydria information; (2) PepTest - a saliva-based reflux detection test; (3) NutriSMART Food Intolerance Test - measuring IgG4 antibodies for 57 foods; and (4) multiple additional laboratory tests including vitamin D, celiac disease, pancreatic function, inflammatory markers, and colon disease screening tests. The workflow combines online self-assessments for gastric function, GI inflammation, small intestine/pancreatic risk, and colon disease risk with diagnostic testing to support diagnosis of digestive disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• GastroPanel A painless 4-biomarker blood test (Pepsinogen I, Pepsinogen II, Gastrin-17, H. pylori IgG antibodies) that provides information on stomach mucosa status, H. pylori infection, achlorhydria, and estimates risk of vitamin B12 or micronutrient deficiency. Designed for patients and clinicians seeking a non-invasive alternative to gastroscopy.
• Peptest An immunological in-vitro diagnostic test that measures pepsin (a stomach enzyme) in saliva using two pepsin monoclonal antibodies to conclusively detect reflux and identify when it is occurring. Used by clinicians and patients for non-invasive reflux diagnosis.
• NutriSMART Food Intolerance Test Blood test that measures IgG4 antibody reactivity to 57 of the most common foods from a single drop of blood, with results in 30 minutes. Used to identify food intolerances and support management of IBS symptoms and intestinal permeability (leaky gut).
• Online Risk Assessments A bundle of four online self-assessment tools that evaluate risk of gastric function issues, gastrointestinal inflammation, small intestine and pancreatic disorders, and colon disease. Delivers immediate results to guide users toward the appropriate GastroLab diagnostic test.
• FilmArray GI Panel Molecular multiplex panel testing for the most common gastrointestinal pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea. Used by clinicians for comprehensive pathogen identification.
• BioHit Calprotectin ELISA Quantitative stool test providing differentiation between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) by measuring calprotectin levels. Used by clinicians to triage patients away from unnecessary invasive workup.
• ColonView Quick Test Lateral flow quick test for detection of fecal occult blood (FOB) using immunochemical detection of hemoglobin and hemoglobin/haptoglobin complex. Used to screen for colorectal cancer.
• Celiac Disease Quick Test
• IDK Pancreatic Elastase Stool test using pancreatic elastase as a biomarker for diagnosis and exclusion of exocrine pancreas insufficiency.
• BioHit Active B12 (holotranscobalamin) Test Direct measurement of biochemically active vitamin B12 (holoTC) from serum for screening patients with suspected vitamin B12 deficiency.
• BioHit Total 25OH Vitamin D ELISA Quantitative immunoenzymatic assay for detecting vitamin D2 and D3 to assess vitamin D status, validated against ID-LC/MS-MS Reference Measurement Procedure.
• IDK Zonulin Test Test for zonulin levels used in assessment of intestinal barrier function and celiac disease.
• IDK Gluten Fecal Test Test for gluten-induced autoimmune reaction used in monitoring celiac disease symptoms.

Quantifiable outcome

• Reduced unnecessary invasive procedures (gastroscopy)
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• BioHitcoreTechnology or IntegrationPrimary technology partner providing GastroPanel tests, Vitamin D ELISA kits, Calprotectin ELISA, Active B12 tests, and ColonView FOB tests. GastroLab is the first medical institution in India to use BioHit's advanced gastro diagnostic technology.
• RDBIOMEDcoreTechnology or IntegrationTechnology partner providing Peptest - a non-invasive saliva test for detecting reflux by measuring pepsin levels. Uses proprietary monoclonal antibody technology for in-vitro diagnostic detection.
• ImmunodiagnosticssupportingTechnology or IntegrationPartner providing α1-antitrypsin tests for detecting intestinal protein loss and mucosal permeability issues.
• DST DiagnosticssupportingTechnology or IntegrationPartner providing NutriSMART Food Intolerance Test that measures IgG4 antibody reactivity to 57 common foods from a single blood drop in 30 minutes.
• BioMeriuxsupportingTechnology or IntegrationPartner providing FilmArray GI Panel for comprehensive testing of gastrointestinal pathogens including viruses, bacteria, and parasites that cause infectious diarrhea.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Doctor's Data: Specialty reference lab focused on stool, blood, and saliva testing with deep coverage of digestive and metabolic panels, directly comparable in test menu and physician-referred service model.
• Genova Diagnostics: Specialty clinical laboratory offering non-invasive biomarker and stool-based GI tests for gut health, food sensitivities, H. pylori, and IBS-related diagnostics, mirroring GastroLab's portfolio of non-invasive gastrointestinal panels.

Emerging players

• Everlywell: U.S.-based direct-to-consumer digital health testing brand offering at-home kits for food sensitivity, gut health, and hormone biomarkers, mirroring GastroLab's product-led online assessment-driven DTC testing motion.
• DayTwo: Microbiome-based personalized nutrition company using GI-related diagnostics to drive gut health programs, comparable to GastroLab in coupling non-invasive GI testing with downstream health recommendations.
• Viome Life Sciences: Direct-to-consumer microbiome and gut-health testing brand with saliva/stool sampling and personalized nutrition output, comparable in D2C positioning around non-invasive GI diagnostic content.

Broad incumbents

• SRL Diagnostics: Major Indian pathology lab network with broad blood, stool, and molecular test coverage, comparable in distribution but broader than GastroLab's GI-focused specialty positioning.
• Dr. Lal PathLabs: Largest Indian diagnostic chain with extensive partner-hospital relationships and home-collection services, a comparable broad-spectrum diagnostic operator that could encroach on GastroLab's specialty panels.
• Metropolis Healthcare: Pan-India diagnostic chain delivering routine and specialty blood/serology testing via a partner lab and home-collection network, analogous to GastroLab's hybrid D2C-plus-hospital model at far greater scale.
• Thyrocare Technologies: Large pan-Indian preventive and routine diagnostic testing chain offering home collection and partner-network blood tests, overlapping GastroLab's D2C test ordering and B2B outreach model.

Others

• BioMérieux (BioHit): Owner of the BioHit gastro diagnostic product line that GastroLab distributes in India; comparable as the underlying technology vendor whose products GastroLab markets and applies clinically.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/GastroLab_India
• YouTubeyoutube.com/user/innovatingforhealth
• Facebookfacebook.com/HealthyStomach
• LinkedInlinkedin.com/company/gastrolabindia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GastroLab India Pvt. Ltd